Short Interest in iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Expands By 205.9%

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) was the recipient of a significant growth in short interest in the month of December. As of December 15th, there was short interest totaling 4,328 shares, a growth of 205.9% from the November 30th total of 1,415 shares. Based on an average daily trading volume, of 1,514 shares, the short-interest ratio is presently 2.9 days. Approximately 2.9% of the company’s shares are sold short. Approximately 2.9% of the company’s shares are sold short. Based on an average daily trading volume, of 1,514 shares, the short-interest ratio is presently 2.9 days.

iShares Neuroscience and Healthcare ETF Stock Performance

IBRN stock traded down $0.15 on Friday, reaching $32.47. The company’s stock had a trading volume of 496 shares, compared to its average volume of 792. The business has a fifty day simple moving average of $30.56 and a two-hundred day simple moving average of $26.55. iShares Neuroscience and Healthcare ETF has a 12-month low of $17.86 and a 12-month high of $33.32. The firm has a market cap of $4.87 million, a PE ratio of 15.61 and a beta of 0.93.

About iShares Neuroscience and Healthcare ETF

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.